Lidocaine for chemical cardioversion of orthodromic atrioventricular reciprocating tachycardia in dogs.

Lidocaine successfully cardioverted OAVRT in 84.4% of dogs in our study before adverse effects precluded additional dosing. In 5 dogs with dose limited by adverse effects, it is unknown whether cardioversion would have occurred at a higher cumulative dose.